Medical inflation and increasing health demands are making healthcare more expensive. Instead of cancelling your medical scheme, here’s how to adjust your plan to stay covered without breaking the bank.
Gap cover can protect your clients’ retirement savings and long-term goals from unexpected medical expenses.
The demand for GLP-1 medications as a weight-loss solution raises critical questions about accessibility, affordability, and the long-term sustainability of their use for managing obesity and diabetes.
Downgrading to a lower plan may appear to be a cost-saving strategy, but it frequently results in increased out-of-pocket expenses.
Bidvest Life’s Nic Smit suggests shifting from the traditional approach of leading with death coverage to focusing on income protection when engaging younger clients.
Bestmed states pending rules for low-cost benefit options have further complicated efforts to reduce costs for members.
How to show your clients that gap cover can be the missing piece in their overall healthcare and financial protection strategy.
Contribution increases in 2025 are exceeding CPI, with some medical schemes aiming to rebuild reserves and ensure long-term sustainability.
Bestmed says that rand for rand its benefit options will remain competitive despite the proposed average increase of 12.75%.
Judgment is ‘forthcoming’ in the contempt of court case against the Road Accident Fund and its CEO, as Discovery Health seeks the enforcement of court rulings regarding unpaid claims.
With major medical schemes reporting average contribution hikes exceeding 9%, members face tough choices in an increasingly unaffordable healthcare landscape.
The annual benefit escalations for policies that fall under the Demarcation Regulations.
Aon’s Global Medical Trend Rates Report highlights the pressing challenge of healthcare affordability for businesses amid a decade-high global medical trend rate.
The difference between medical scheme cover and medical insurance – and where gap cover fits in.
Paul Hutchinson, sales manager at Ninety One, recommends growth-focused investments to protect against long-term economic changes – and inflation.
The exemption will remain in force for 12 months unless a decision is made on low-cost benefit options before 31 March 2025.
